Structural Interventions

Stroke Risk Reduction

The Amplatzer portfolio of structural intervention occluders provides minimally invasive treatment options for the closure of congenital heart defects and for stroke risk reduction. The closure procedures are performed through a transcatheter approach, which prevents the need for open heart surgery and enables faster recovery times.

Structural Interventions: Stroke Risk Reduction

Amplatzer™ Talisman™ PFO Occluder

The Amplatzer™ Talisman™ PFO Occluder set the standard, pioneering treatment with a device developed specifically for patent foramen ovale (PFO) closure to reduce the risk of recurrent ischemic stroke. It’s the leading PFO closure device to date, with over 180,000 devices implanted worldwide.1

Amplatzer Talisman PFO Occluder

Amplatzer™ Amulet™ Left Atrial Appendage Occluder

The Amplatzer™ Amulet™ Left Atrial Appendage Occluder is the only FDA-approved LAA occluder that offers immediate freedom from OACs. With unique dual seal technology to ensure immediate and complete closure and the widest range of sizes of any LAA occluder, Amulet™ makes closure an option for more AFib patients.2

Amplatzer Amulet Occluder


  1. Data on file at Abbott.
  2. Amplatzer Amulet LAA Occluder IFU. 

MAT-2304770 v1.0